At Signant Health, we combine our technology with robust clinical, scientific, and regulatory expertise to guide your study from design to regulatory submission. In this video series, Chief Medical Officer Dawie Wessels leads discussions with a selection of our in-house clinicians, scientists, medical practitioners, and key opinion leaders about how they ensure the best practices and solutions are in place to help clinical research programs succeed.

Want to Learn More?

DAWIE WESSELS
CHIEF MEDICAL OFFICER

Hosted By

Optimizing Pediatric Trials to Generate High Quality Data for Regulatory Decision-Making  

 
+ More details

JOAN BUSNER, PhD
Clinical Vice President
Pediatrics, Orphan Diseases, Mood & Anxiety 

CONNECT WITH SIGNANT

EPISODE 1

EPISODE 2

 

Patient Selection and Monitoring Ratings Validity in Mood Disorder Trials  

GARY SACHS, PhD
Clinical Vice President
Bipolar & Other Mood Disorders

+ More details

EPISODE 3

EPISODE 4

 
 

Optimizing Oncology Trials to Generate High-Quality Data for Regulatory Decision-Making

Seeking Signal Detection in Schizophrenia Trials: Lessons Learned  

DAVID DANIEL, PhD
Sr. Vice President
CNS Medicine

TODD EVERHART, MD
Clinical Vice President
Internal Medicine

+ More details+ More details

EPISODE 5

EPISODE 6

 
 

Important Considerations for the Successful Migration of eCOA  

Optimal eCOA for 
Vaccine Trials  

STEPHAN BART, SR MD CPI
Executive Advisor
Infectious Disease, Vaccines

DAN DeBONIS
Principal
Endpoint Solutions

+ More details+ More details

BILL BYROM, PhD
Principal
eCOA Science

+ EPISODE GUIDE

EPISODE 7

EPISODE 8

 
 

Baseline Score Inflation: 
Detection, Impact, and Mitigation

The Double-Blind Placebo Run In: To Be or Not to Be?   

STEVE TARGUM, MD
Scientific Director,
Schizophrenia & Mood Disorders

GARY SACHS, MD
Clinical Vice President
Bipolar & Other Mood Disorders 

+ More details+ More details

ALAN KOTT, MUDr
Clinical Vice President 
Data Analytics 

CONNECT WITH SIGNANT